Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Net Income: 2023-2024

Historic Net Income for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to -$161.3 million.

  • Zenas BioPharma's Net Income fell 33.40% to -$51.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$193.8 million, marking a year-over-year decrease of 50.07%. This contributed to the annual value of -$161.3 million for FY2024, which is 334.62% down from last year.
  • As of FY2024, Zenas BioPharma's Net Income stood at -$161.3 million, which was down 334.62% from -$37.1 million recorded in FY2023.
  • Zenas BioPharma's 5-year Net Income high stood at -$37.1 million for FY2023, and its period low was -$161.3 million during FY2024.
  • For the 2-year period, Zenas BioPharma's Net Income averaged around -$99.2 million, with its median value being -$99.2 million (2023).
  • Data for Zenas BioPharma's Net Income shows a maximum YoY plummeted of 334.62% (in 2024) over the last 5 years.
  • Zenas BioPharma's Net Income (Yearly) stood at -$37.1 million in 2023, then plummeted by 334.62% to -$161.3 million in 2024.